- cafead Oct 15, 2023 at 11:52: PM
via European Union (EU) regulators have delayed a decision to give approval for Novavax's (NVAX.O) variant-tailored COVID-19 vaccine, the company said on Sunday.
The European Medicines Agency (EMA) has requested more information from Novavax on the shot, which targets the XBB variant, the company said.
article source
The European Medicines Agency (EMA) has requested more information from Novavax on the shot, which targets the XBB variant, the company said.
article source